Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest Diagnostics Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
Contrasting Quest Diagnostics (NYSE:DGX) and HealthStream (HSTM)
Quest Diagnostics (NYSE: DGX) and HealthStream (NASDAQ:HSTM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitabiliy, earnings and valuation.
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest Diagnostics Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
Volatility and Risk
Quest Diagnostics has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.
Valuation and Earnings
This table compares Quest Diagnostics and HealthStream’s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| Quest Diagnostics | $7.55 billion | 1.98 | $1.42 billion | $4.96 | 22.08 |
| HealthStream | $231.77 million | 3.13 | $21.62 million | $0.14 | 162.36 |
Quest Diagnostics has higher revenue and earnings than HealthStream. Quest Diagnostics is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Quest Diagnostics and HealthStream’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Quest Diagnostics | 9.28% | 15.66% | 7.24% |
| HealthStream | 1.85% | 2.27% | 1.65% |
Analyst Ratings
This is a summary of recent ratings and target prices for Quest Diagnostics and HealthStream, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Quest Diagnostics | 0 | 7 | 6 | 1 | 2.57 |
| HealthStream | 0 | 3 | 4 | 0 | 2.57 |
Quest Diagnostics presently has a consensus price target of $109.11, indicating a potential downside of 0.37%. HealthStream has a consensus price target of $26.00, indicating a potential upside of 14.39%. Given HealthStream’s higher probable upside, analysts clearly believe HealthStream is more favorable than Quest Diagnostics.
Dividends
Quest Diagnostics pays an annual dividend of $1.80 per share and has a dividend yield of 1.6%. HealthStream does not pay a dividend. Quest Diagnostics pays out 36.3% of its earnings in the form of a dividend. Quest Diagnostics has raised its dividend for 5 consecutive years.
Institutional and Insider Ownership
90.8% of Quest Diagnostics shares are owned by institutional investors. Comparatively, 77.0% of HealthStream shares are owned by institutional investors. 1.5% of Quest Diagnostics shares are owned by insiders. Comparatively, 21.1% of HealthStream shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Quest Diagnostics beats HealthStream on 11 of the 17 factors compared between the two stocks.
Quest Diagnostics Company Profile
HealthStream Company Profile